BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1177 related articles for article (PubMed ID: 33574015)

  • 1. Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
    Azenha Rama T; Álvarez-Twose I
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):193-195. PubMed ID: 33574015
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
    Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
    Moghimi SM
    Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
    [No Abstract]   [Full Text] [Related]  

  • 4. mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
    Rama TA; Moreira A; Castells M
    J Allergy Clin Immunol; 2021 Mar; 147(3):877-878. PubMed ID: 33485650
    [No Abstract]   [Full Text] [Related]  

  • 5. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
    Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
    [No Abstract]   [Full Text] [Related]  

  • 6. Maintaining Safety with SARS-CoV-2 Vaccines.
    Castells MC; Phillips EJ
    N Engl J Med; 2021 Feb; 384(7):643-649. PubMed ID: 33378605
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.
    Erdeljic Turk V
    Clin Immunol; 2021 Jun; 227():108748. PubMed ID: 33932618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
    Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
    Front Immunol; 2021; 12():669010. PubMed ID: 34093567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy.
    Soeiro T; Salvo F; Pariente A; Grandvuillemin A; Jonville-Béra AP; Micallef J
    Therapie; 2021; 76(4):365-367. PubMed ID: 33858693
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
    Peter J
    S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How COVID unlocked the power of RNA vaccines.
    Dolgin E
    Nature; 2021 Jan; 589(7841):189-191. PubMed ID: 33437061
    [No Abstract]   [Full Text] [Related]  

  • 12. Latent Mastocytosis Triggered by COVID-19 Vaccination: A Case Report.
    Calogiuri G; Foti C; Congedo M; Nettis E; Paladini L; Greco G; Pavone V; Vacca A
    Endocr Metab Immune Disord Drug Targets; 2024; 24(4):495-498. PubMed ID: 37817657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Covid-19 vaccination and risk of anaphylaxis - Recommendations for practical management].
    Worm M; Ring J; Klimek L; Jakob T; Lange L; Treudler R; Beyer K; Werfel T; Biedermann T; Bircher A; Fischer M; Fuchs T; Heller AR; Hoffmann F; Huttegger I; Kopp MV; Kugler C; Lommatzsch M; Pfaar O; Rietschel E; Rueff F; Schnadt S; Seifert R; Stöcker B; Vogelberg C; Sitter H; Gieler U; Brockow K
    MMW Fortschr Med; 2021 Jan; 163(1):48-51. PubMed ID: 33464512
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of mRNA-Based Vaccines for SARS CoV-2.
    Barda B; Cerny A
    Chem Res Toxicol; 2021 Aug; 34(8):1823-1825. PubMed ID: 34009959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [COVID-19 vaccines increase the risk of anaphylaxis].
    Alnæs M; Storaas T; Sørensen M; Stylianou E; Tøndell A
    Tidsskr Nor Laegeforen; 2021 Mar; 141(4):. PubMed ID: 33685103
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute Allergic Reactions to mRNA COVID-19 Vaccines.
    Blumenthal KG; Robinson LB; Camargo CA; Shenoy ES; Banerji A; Landman AB; Wickner P
    JAMA; 2021 Apr; 325(15):1562-1565. PubMed ID: 33683290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results.
    Lombardi A; Bozzi G; Ungaro R; Villa S; Castelli V; Mangioni D; Muscatello A; Gori A; Bandera A
    Front Immunol; 2021; 12():657711. PubMed ID: 33777055
    [No Abstract]   [Full Text] [Related]  

  • 18. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
    Maeda M; Isawa T; Tada N
    Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination.
    Dages KN; Pitlick MM; Joshi AY; Park MA
    Ann Allergy Asthma Immunol; 2021 Aug; 127(2):257-258. PubMed ID: 33962029
    [No Abstract]   [Full Text] [Related]  

  • 20. Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents.
    Schauer J; Buddhe S; Colyer J; Sagiv E; Law Y; Mallenahalli Chikkabyrappa S; Portman MA
    J Pediatr; 2021 Nov; 238():317-320. PubMed ID: 34228985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.